Understanding Vaccine Varieties: A Social Pharmacy Perspective

What are Vaccines in Social Pharmacy?

A vaccine is a biological preparation that stimulates the immune system of an individual to recognize and defend against specific pathogens, such as viruses or bacteria. Vaccines typically contain weakened, killed, or parts of the targeted pathogen, known as antigens, which trigger an immune response without causing the disease itself.

This immune response allows the body to produce antibodies and memory cells that can rapidly recognize and neutralize the pathogen if encountered in the future, providing immunity against the disease. Vaccines are essential tools in preventing infectious diseases and are used widely in public health initiatives to protect individuals and communities from illness.

Types of Vaccines

There are several types of vaccines, each employing different mechanisms to stimulate the immune system. Here’s an explanation of some common types:

1. Live Attenuated Vaccines: These vaccines contain weakened forms of the live pathogen that causes the disease. Although they are not capable of causing illness in healthy individuals, they can still induce a strong immune response. Examples include the measles, mumps, and rubella (MMR) vaccine and the oral polio vaccine (OPV).
2. Inactivated Vaccines: These vaccines consist of killed pathogens or parts of pathogens. They cannot cause the disease because the pathogen is no longer viable. However, they still contain antigens that trigger an immune response. Inactivated vaccines often require booster doses to maintain immunity. Examples include the influenza (flu) vaccine and the hepatitis A vaccine.
3. Subunit, Recombinant, and Conjugate Vaccines: These vaccines contain only specific parts of the pathogen, such as proteins or polysaccharides, rather than the whole organism. They are often safer than live attenuated vaccines because they cannot cause the disease. Subunit vaccines may include recombinant DNA technology to produce the antigen. Conjugate vaccines combine antigens from the pathogen with carrier proteins to enhance the immune response, particularly in young children. Examples include the hepatitis B vaccine (subunit), the human papillomavirus (HPV) vaccine (recombinant), and the Haemophilus influenzae type b (Hib) vaccine (conjugate).
4. Viral Vector Vaccines: These vaccines use a harmless virus, known as a viral vector, to deliver genetic material from the target pathogen into host cells. The host cells then produce antigens, triggering an immune response. Viral vector vaccines can induce strong and long-lasting immunity. Examples include the Johnson & Johnson COVID-19 vaccine and the Ebola vaccine.
5. Nucleic Acid Vaccines (RNA and DNA Vaccines): These vaccines contain genetic material, either RNA or DNA, that encodes the antigen of the target pathogen. Once inside the body, host cells use this genetic material to produce antigens, stimulating an immune response. Nucleic acid vaccines are relatively new but offer potential advantages, such as rapid development and scalability. The Pfizer-BioNTech and Moderna COVID-19 vaccines are examples of mRNA vaccines.

Each type of vaccine has its own advantages, limitations, and considerations regarding storage, administration, and efficacy. The choice of vaccine type depends on factors such as the characteristics of the pathogen, the desired immune response, and practical considerations for vaccine deployment.

What’s the difference between a live and a non-live vaccine?

The primary difference between live (or attenuated) vaccines and non-live (or inactivated) vaccines lies in the nature of the pathogens used to create them and how they stimulate the immune system.

No.	Live (Attenuated) Vaccines	Non-Live (Inactivated) Vaccines
1.	Live vaccines contain weakened forms of the actual virus or bacteria that causes the disease they protect against. These weakened pathogens are called “attenuated” because they are no longer capable of causing severe illness in vaccinated individuals.	Non-live vaccines contain killed or inactivated forms of the virus or bacteria. These pathogens are no longer capable of causing disease but can still stimulate an immune response.
2.	Live vaccines replicate and produce an immune response in a similar way to natural infections, leading to long-lasting immunity.	Non-live vaccines may contain whole, inactivated pathogens or only specific parts of the pathogen, such as proteins or sugars.
3.	Live vaccines carry a small risk of causing mild symptoms or, rarely, a more severe reaction, particularly in individuals with weakened immune systems.	Non-live vaccines typically require additional components called adjuvants to enhance the immune response.
4.	Live vaccines often provide long-lasting immunity with a single or few doses.	Non-live vaccines may require booster doses to maintain immunity over time.
5.	Examples of live vaccines include the measles, mumps, rubella (MMR) vaccine, oral polio vaccine (OPV), and varicella (chickenpox) vaccine.	Examples of non-live vaccines include the influenza vaccine, hepatitis A vaccine, and the injected polio vaccine (IPV).

How Do Vaccines Work?

Vaccines work by stimulating the body’s immune system to recognize and remember specific pathogens, such as viruses or bacteria, without causing the disease itself. Here’s a simplified explanation of how vaccines work:

1. Introduction of Antigens: When you receive a vaccine, it introduces harmless versions of the pathogen, such as weakened or inactivated forms, or specific parts of the pathogen, called antigens, into your body. These antigens mimic the presence of the actual pathogen, triggering an immune response.
2. Activation of Immune Response: The immune system recognizes the antigens as foreign invaders and mounts a defense. This process involves the activation of various immune cells, including antigen-presenting cells (such as dendritic cells), T cells, and B cells.
3. Production of Antibodies: B cells, a type of white blood cell, produce antibodies specific to the antigens present in the vaccine. Antibodies are proteins that bind to and neutralize the pathogens or their toxins, preventing them from causing infection.
4. Generation of Memory Cells: Along with producing antibodies, the immune system generates memory cells. These cells “remember” the specific pathogen encountered and remain in the body even after the initial immune response has resolved. If the body is exposed to the same pathogen in the future, memory cells can quickly recognize and mount a rapid, targeted immune response, preventing or minimizing illness.
5. Long-Term Immunity: Vaccination leads to the establishment of long-term immunity against the targeted pathogen. This immunity can provide protection for years or even a lifetime, depending on the vaccine and individual factors.

By harnessing the body’s natural immune response, vaccines help to train and prepare the immune system to recognize and respond effectively to pathogens, thereby preventing infection or reducing the severity of disease if infection does occur. Vaccines have been instrumental in controlling and eradicating many infectious diseases and are considered one of the most successful public health interventions in history.

You May Like: Define Pandemic and Its Phases according to WHO

How do Live Attenuated Vaccines Work?

Live attenuated vaccines contain weakened forms of the live pathogens that cause diseases. These weakened pathogens are created through a process called attenuation, which involves modifying the pathogen to reduce its virulence (ability to cause disease) while still retaining its ability to stimulate an immune response.

Here’s how live attenuated vaccines work:

1. Introduction of Weakened Pathogen: When you receive a live attenuated vaccine, the weakened form of the pathogen is introduced into your body. This weakened pathogen is typically unable to cause illness in healthy individuals because it has been modified in a laboratory to reduce its ability to replicate and cause disease.
2. Immune Response Activation: Despite being weakened, the live attenuated pathogen is still recognized as foreign by your immune system. This triggers an immune response similar to what would occur during a natural infection.
3. Production of Antibodies and Memory Cells: Your immune system responds to the presence of the weakened pathogen by producing antibodies, which are proteins that bind to and neutralize the pathogen. Additionally, memory cells are generated as part of the immune response. These memory cells “remember” the specific pathogen encountered and remain in the body, providing long-lasting immunity.
4. Protection Against Future Infections: Because live attenuated vaccines stimulate a robust immune response, they can provide strong and long-lasting immunity against the targeted disease. If you are exposed to the actual pathogen in the future, your immune system can quickly recognize and mount a rapid response, preventing or minimizing illness.

It’s important to note that live attenuated vaccines should not be administered to individuals with weakened immune systems, as there is a risk that the weakened pathogen in the vaccine could cause illness in these individuals. Additionally, live attenuated vaccines may require refrigeration to maintain their effectiveness, as the weakened pathogens may still be capable of replication to some extent. Examples of live attenuated vaccines include the measles, mumps, and rubella (MMR) vaccine and the oral polio vaccine (OPV).

---

How are Vaccines Made?

Vaccines are developed through a complex process involving several stages, including research, development, testing, and manufacturing. Here’s a general overview of how vaccines are made:

1. Exploration and Research: Scientists identify a target pathogen (such as a virus or bacterium) that causes a specific disease. They study the biology of the pathogen, including its structure, behavior, and how it interacts with the immune system.
2. Designing the Vaccine: Based on their understanding of the pathogen, scientists design a vaccine to stimulate the body’s immune response against it. There are several types of vaccines, including live attenuated vaccines, inactivated vaccines, subunit vaccines, mRNA vaccines, and vector vaccines. The type of vaccine chosen depends on factors such as the nature of the pathogen, safety concerns, and the desired immune response.
3. Preclinical Testing: In this stage, the vaccine candidate is tested in the laboratory and in animal models to evaluate its safety and efficacy. Scientists assess whether the vaccine induces an immune response and protects against the target disease.
4. Clinical Trials: If the vaccine candidate shows promise in preclinical testing, it progresses to clinical trials, which involve testing the vaccine in humans. Clinical trials typically consist of three phases:
   • Phase I: The vaccine is administered to a small group of healthy volunteers to evaluate its safety and determine the appropriate dosage.
   • Phase II: The vaccine is given to a larger group of people to further assess its safety, immunogenicity (the ability to produce an immune response), and optimal dosage.
   • Phase III: The vaccine is administered to thousands of people to evaluate its safety and efficacy in preventing the target disease. This phase provides crucial data on the vaccine’s effectiveness and potential side effects.
5. Regulatory Approval: If the vaccine successfully completes all phases of clinical trials and meets safety and efficacy standards, regulatory agencies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) review the data and decide whether to approve the vaccine for use.
6. Manufacturing: Once the vaccine receives regulatory approval, it undergoes large-scale manufacturing. This involves producing the vaccine in specialized facilities under strict quality control measures. The manufacturing process may vary depending on the type of vaccine but generally includes growing the pathogen (if it’s a live attenuated or inactivated vaccine), purifying the antigen (the part of the pathogen that stimulates the immune response), and formulating the vaccine for administration.
7. Distribution and Administration: The manufactured vaccines are distributed to healthcare providers and administered to the public through vaccination programs. Storage and distribution requirements vary depending on the vaccine’s characteristics (e.g., temperature sensitivity).

Throughout this entire process, rigorous testing, quality control, and regulatory oversight are essential to ensure the safety, efficacy, and quality of the vaccines produced.

Importance of Vaccination

Vaccination is the most important thing we can do to protect ourselves and our children against ill health. They prevent millions of deaths worldwide every year. Since vaccines were introduced in the UK, diseases like smallpox, polio and tetanus that used to kill or disable millions of people are either gone or are now very rarely seen.

Other diseases like measles and diphtheria have reduced to a very low number of cases each year since vaccines were introduced. These cases are often related to travel. However, if people stop having vaccines, it’s possible for infectious diseases to quickly spread again

Vaccination plays a crucial role in public health and has numerous important benefits:

1. Disease Prevention: Vaccines are highly effective in preventing infectious diseases caused by bacteria and viruses. By stimulating the immune system to produce antibodies against specific pathogens, vaccines help individuals develop immunity without getting sick from the disease itself.
2. Eradication and Control of Diseases: Vaccination has been instrumental in eradicating or controlling many deadly diseases. For example, vaccines have played a pivotal role in the near-elimination of diseases such as smallpox and polio in many parts of the world.
3. Protection of Vulnerable Populations: Vaccination not only protects vaccinated individuals but also helps protect vulnerable populations such as infants, elderly individuals, pregnant women, and people with weakened immune systems who may be at higher risk of severe complications from infectious diseases.
4. Community Immunity (Herd Immunity): When a significant portion of a population is vaccinated against a disease, it creates community immunity, also known as herd immunity. This phenomenon helps protect individuals who cannot be vaccinated due to medical reasons or those for whom vaccines may be less effective. Herd immunity reduces the overall spread of infectious diseases within a community, making outbreaks less likely.
5. Reduced Healthcare Burden: Vaccination helps reduce the burden on healthcare systems by preventing illnesses, hospitalizations, and deaths associated with vaccine-preventable diseases. This leads to lower healthcare costs and fewer resources needed to treat infectious diseases.
6. Global Health Security: Vaccination is essential for global health security, as infectious diseases can easily spread across borders in our interconnected world. Preventing outbreaks through vaccination efforts helps safeguard global health and security.
7. Prevention of Antibiotic Resistance: Vaccines help prevent the spread of infectious diseases, reducing the need for antibiotics. This, in turn, helps combat antibiotic resistance, which is a growing global health threat.
8. Economic Benefits: Vaccination programs offer substantial economic benefits by reducing healthcare costs, increasing productivity (by preventing illness-related work absences), and averting the economic impact of outbreaks and epidemics on communities and economies.

In summary, vaccination is a cornerstone of public health efforts, offering substantial benefits in preventing diseases, protecting vulnerable populations, promoting global health security, and contributing to economic well-being. It remains one of the most effective and cost-effective interventions available to improve public health and save lives.

Vaccine Safety and Efficacy

Vaccine safety and efficacy are paramount considerations in public health efforts worldwide. This section delves into the rigorous processes and monitoring systems employed to assess and maintain the safety and effectiveness of vaccines, ensuring public confidence and trust.

1. Safety Protocols: Explore the extensive safety protocols implemented at every stage of vaccine development, from preclinical studies to post-market surveillance, to identify and mitigate potential risks.
2. Clinical Trials: Learn about the phases of clinical trials and the meticulous monitoring of participants to evaluate vaccine safety and efficacy before regulatory approval.
3. Post-Market Surveillance: Understand the importance of ongoing monitoring of vaccine safety through robust surveillance systems, including reporting adverse events and conducting epidemiological studies.
4. Adverse Events Reporting: Discover the mechanisms in place for healthcare providers and the public to report adverse events following vaccination, enabling prompt investigation and response.
5. Risk Communication: Examine strategies for transparent communication of vaccine safety information, addressing concerns, and maintaining public trust in vaccination programs.
6. Effectiveness Monitoring: Explore methods for assessing vaccine effectiveness in real-world settings, including studies on vaccine impact, coverage rates, and disease incidence reduction.
7. Global Collaboration: Highlight the significance of international collaboration and data sharing in monitoring vaccine safety and efficacy, facilitating early detection of potential issues and swift intervention.
8. Public Health Impact: Discuss the broader public health impact of vaccines, including their role in reducing disease burden, hospitalizations, and mortality, and the economic benefits of prevention.

By prioritizing vaccine safety and efficacy through comprehensive research, monitoring, and communication, public health authorities aim to uphold the integrity of vaccination programs and protect the well-being of populations worldwide.